WeTrace Health builds compact, home‑based sensing systems that continuously and non‑invasively monitor human biochemistry through daily urine analysis. By quantifying hormone, nutrition, and disease biomarkers in real time, the platform aims to detect conditions such as chronic kidney disease, heart failure, and cancer far earlier than traditional checkups, enabling proactive health management and precision medicine.
Funding
Funding not disclosed
Founders
Product
Problem
Current medical practice relies on periodic checkups that capture only occasional snapshots of a person’s health, missing early biochemical changes that precede disease. Many conditions, such as kidney failure, heart failure, cancer, and Alzheimer’s, could be detected sooner if continuous, non‑invasive monitoring of internal biomarkers were available.
Solution
WeTraceHealth creates compact, home‑based sensing systems that continuously analyze urine chemistry without invasive procedures. By measuring a broad panel of hormones, nutrients, and disease‑related markers daily, the platform delivers real‑time biochemical data to users and clinicians. The continuous data stream enables precision medicine approaches, allowing earlier intervention and more personalized treatment plans. Cloud‑based analytics interpret trends and flag early warning signals for chronic diseases, supporting proactive health management. The system is designed for easy integration into everyday bathroom use, providing quantitative insights without requiring clinic visits.
Target Audience
Primary customers are health‑conscious individuals seeking proactive monitoring and clinicians or health systems that want continuous biochemical data to support early diagnosis and personalized care.
Features
- Compact, plug‑and‑play urine sensor that operates autonomously in a home bathroom setting
- Continuous, non‑invasive measurement of multiple biochemical markers including hormones, nutrition metabolites, and disease‑related compounds
- Real‑time data transmission to a secure cloud platform for longitudinal trend analysis
- Automated alerts that highlight early indicators of chronic conditions such as chronic kidney disease, heart failure, various cancers, Alzheimer’s, and osteoporosis
- Dashboard interface for users and healthcare providers to visualize daily biomarker trajectories and receive actionable insights
- Scalable sensor architecture designed to expand the panel of detectable analytes as new biomarkers are validated